河北北方学院附属第一医院呼吸与危重症监护室,河北 张家口 075000
丁晓霞,E-mail:dingxiaoxia1992@163.com
纸质出版日期:2023-07-25,
收稿日期:2022-05-16,
扫 描 看 全 文
丁晓霞,刘亚群,于小纬等.miR-146b-3p通过靶向结合LCN1抑制肺鳞癌生物学行为[J].局解手术学杂志,2023,32(07):578-585.
DING Xiao-xia,LIU Ya-qun,YU Xiao-wei,et al.miR-146b-3p inhibiting the biological behavior of lung squamous cell carcinoma through targeted binding to LCN1[J].JOURNAL OF REGIONAL ANATOMY AND OPERATIVE SURGERY,2023,32(07):578-585.
丁晓霞,刘亚群,于小纬等.miR-146b-3p通过靶向结合LCN1抑制肺鳞癌生物学行为[J].局解手术学杂志,2023,32(07):578-585. DOI: 10.11659/jjssx.05E022072.
DING Xiao-xia,LIU Ya-qun,YU Xiao-wei,et al.miR-146b-3p inhibiting the biological behavior of lung squamous cell carcinoma through targeted binding to LCN1[J].JOURNAL OF REGIONAL ANATOMY AND OPERATIVE SURGERY,2023,32(07):578-585. DOI: 10.11659/jjssx.05E022072.
目的
2
探讨miR-146b-3p通过靶向结合脂质运载蛋白1(LCN1)抑制肺鳞癌生物学行为的效果。
方法
2
构建稳定过表达miR-146b-3p和稳定敲低LCN1的NCI-H2170和NCI-H226细胞系,CCK-8法和克隆实验检测细胞增殖能力,流式细胞仪检测细胞周期和凋亡情况。生物信息学分析miR-146b-3p和LCN1与肺鳞癌临床病理特征的关系,并预测两者之间的靶向关系。双荧光素酶报告实验验证miR-146b-3p和LCN1的靶向关系。RT-PCR检测miR-146b-3p在肺鳞癌细胞中的表达。裸鼠成瘤实验检测肿瘤体质量、体积和肺鳞癌组织中miR-146b-3p的表达 。Western blot检测细胞蛋白表达。
结果
2
miR-146b-3p在肺鳞癌组织中低表达,肺鳞癌细胞miR-146b-3p过表达后,细胞增殖能力降低,克隆数减少,细胞周期受到阻滞,细胞凋亡率增加,裸鼠移植瘤生长受到抑制,BCL2、CCNB1和CDK2蛋白减少,BAX蛋白增加,差异均有统计学意义(
P
<
0.05)。LCN1在肺鳞癌组织中高表达,敲低LCN1表达可抑制肺鳞癌细胞增殖,影响细胞周期,促进细胞凋亡,差异均有统计学意义(
P
<
0.05)。生物信息学分析显示,LCN1是miR-146b-3p的靶基因;双荧光素酶报告实验显示miR-146b-3p mimic与LCN1-WT共转染使荧光素酶活性降低(
P
<
0.05)。肺鳞癌细胞共转染miR-146b-3p和LCN1后,可以逆转miR-146b-3p抑制细胞增殖和克隆、促凋亡的作用。
结论
2
miR-146b-3p可能是通过下调LCN1表达抑制肺鳞癌细胞增殖,影响细胞周期,促进细胞凋亡。
Objective
2
To explore the effect of miR-146b-3p in inhibiting the biological behavior of lung squamous cell carcinoma by targeted binding to lipocalin-1 (LCN1).
Methods
2
NCI-H2170 and NCI-H226 cell lines with stable overexpression of miR-146b-3p and stable knockdown of LCN1 were constructed. The cell proliferation was detected by CCK-8 assay and clone formation assay. The cell cycle and apoptosis were detected by flow cytometry. Bioinformatics analysis was used to analyze the relationships of miR-146b-3p and LCN1 with clinicopathological features of lung squamous cell carcinoma, and predict the targeted relationship of miR-146b-3p and LCN1. The targeted relationship between miR-146b-3p and LCN1 was verified by dual-luciferase reporter assay.The expression of miR-146b-3p in lung squamous cell carcinoma cells was detected by RT-PCR. The mass and volume of tumors and expression of miR-146b-3p in lung squamous cell carcinoma tissues were detected by the tumor formation assay in nude mice. The expression of different proteins were detected by Western blot.
Results
2
The expression of miR-146b-3p was down-regulated in lung squamous cell carcinoma tissues. After overexpression of miR-146b-3p in lung squamous cell carcinoma cells, the cell proliferation ability decreased, the number of clones reduced, the cell cycle was blocked, the apoptosis rate increased, the growths of transplanted tumor in nude mice was inhibited, the protein expression of BCL2, CCNB1 and CDK2 decreased, and the protein expression of BAX increased,with statistically significant differences (
P
<
0.05). The expression of LCN1 was up-regulated in lung squamous cell carcinoma tissues,knockdown LCN1 could inhibit the proliferation of lung squamous cell carcinoma cells, affect cells cycle and promote cell apoptosis, with statistically significant differences (
P
<
0.05). Bioinformatics analysis showed that LCN1 was the targeted gene of miR-146b-3p. Dual-luciferase reporter assay showed that the luciferase activity was decreased after the co-transfection of miR-146b-3p mimic and LCN1-WT (
P
<
0.05). After co-transfection of miR-146b-3p and LCN1, lung squamous cell carcinoma cells could reverse the effect of miR-146b-3p in inhibiting cell proliferation, cloning, and pro-apoptosis.
Conclusion
2
miR-146b-3p can inhibit the proliferation of lung squamous cell carcinoma cells, affect cells cycle and promote apoptosis by down-regulating the expression of LCN1.
miR-146b-3p肺鳞癌增殖脂质运载蛋白1
miR-146b-3plung squamous cell carcinomaproliferationlipocalin-1
Schabath MB, Cote ML.Cancer progress and priorities:lung cancer[J].Cancer Epidemiol Biomarkers Prev,2019,28(10):1563-1579.doi:10.1158/1055-9965.EPI-19-0221http://dx.doi.org/10.1158/1055-9965.EPI-19-0221.
张明光,徐海军,施联善,等.基于Logistic回归模型构建联合检测因子对非小细胞肺癌EGFR突变状态的预测价值[J].分子诊断与治疗杂志,2021,13(2):259-262.doi:10.3969/j.issn.1674-6929.2021. 02.023http://dx.doi.org/10.3969/j.issn.1674-6929.2021.02.023.
Wang BY,Huang JY,Chen HC,et al.The comparison between adenocarcinoma and squamous cell carcinoma in lung cancer patients[J].J Cancer Res Clin Oncol,2020,146(1):43-52.doi: 10.1007/s00432-019-03079-8http://dx.doi.org/10.1007/s00432-019-03079-8.
张兰兰,李向敏,毛志远,等.2例肺腺癌EGFR-TKIs耐药后转化小细胞肺癌的病例报道及文献回顾[J].空军医学杂志,2021,37(3):262-265.doi:10.3969/j.issn.2095-3402.2021.03.021http://dx.doi.org/10.3969/j.issn.2095-3402.2021.03.021.
Chen L,Heikkinen L,Wang C,et al.Trends in the development of miRNA bioinformatics tools[J].Brief Bioinform,2019,20(5):1836-1852.doi: 10.1093/bib/bby054http://dx.doi.org/10.1093/bib/bby054.
田莲莲,朱军,马骞,等.胃癌VEGF通路相关基因的预后模型的构建[J].空军医学杂志,2021,37(3):227-231.doi:10.3969/j.issn.2095-3402.2021.03.012http://dx.doi.org/10.3969/j.issn.2095-3402.2021.03.012.
彭俊付,王振彪,彭继升,等.miR-142-3p靶向Wnt/β-链蛋白通路对结直肠癌细胞增殖的影响[J].临床误诊误治,2021,34(4):81-86.doi:10.3969/j.issn.1002-3429.2021.04.017http://dx.doi.org/10.3969/j.issn.1002-3429.2021.04.017.
刘倩峰,庞超,李庆星,等.miR-365-3p抑制CDK-10表达对口腔鳞癌细胞增殖、凋亡和周期的影响[J].中南医学科学杂志,2021,49(1):35-40.doi:10.15972/j.cnki.43-1509/r.2021.01.007http://dx.doi.org/10.15972/j.cnki.43-1509/r.2021.01.007.
付明刚,迪丽米娜·伊拉木,郭丽英.miR-146a在早期乳腺浸润性导管癌组织中的表达及临床意义[J].新疆医科大学学报,2018,41(6):715-717.doi:10.3969/j.issn.1009-5551.2018.06.013http://dx.doi.org/10.3969/j.issn.1009-5551.2018.06.013.
Yin Z,Cui Z,Ren Y,et al.MiR-146a polymorphism correlates with lung cancer risk in Chinese nonsmoking females[J].Oncotarget,2017,8(2):2275-2283.doi: 10.18632/oncotarget.13722http://dx.doi.org/10.18632/oncotarget.13722.
沙杰,范理宏.miRNA-146b-3p在早期非小细胞肺癌中的诊断价值[J].同济大学学报(医学版),2018,39(2):73-78.doi:10.16118/j.1008-0392.2018.02.014http://dx.doi.org/10.16118/j.1008-0392.2018.02.014.
Yoshimatsu Y,Ebi N,Ooi R,et al.Osimertinib for lung squamous cell carcinoma:a case report and literature review[J].Intern Med,2021,60(7):1067-1071.doi: 10.2169/internalmedicine.5463-20http://dx.doi.org/10.2169/internalmedicine.5463-20.
Pathak G,Singh S,Kumari P,et al.Cirsimaritin,a lung squamous carcinoma cells (NCIH-520) proliferation inhibitor[J].J Biomol Struct Dyn,2021,39(9):3312-3323.doi: 10.1080/07391102.2020. 1763198http://dx.doi.org/10.1080/07391102.2020.1763198.
Swarbrick S,Wragg N,Ghosh S,et al.Systematic review of miRNA as biomarkers in Alzheimer's disease[J].Mol Neurobiol,2019,56(9):6156-6167.doi: 10.1007/s12035-019-1500-yhttp://dx.doi.org/10.1007/s12035-019-1500-y.
张玲玲,张莹,热依娜·乌甫里.质量管理模式对肿瘤患者护理质量的影响[J].解放军医院管理杂志,2021,28(10):981-983.doi:10.16770/J.cnki.1008-9985.2021.10.030http://dx.doi.org/10.16770/J.cnki.1008-9985.2021.10.030.
章必成,许斌,姚颐,等.综合性大学开设肿瘤学通识课的实践研究[J].中华医学教育探索杂志,2021,20(2):150-152.doi: 10.3760/cma.j.cn116021-20191227-00389http://dx.doi.org/10.3760/cma.j.cn116021-20191227-00389.
王昊,袁建松.消化道恶性肿瘤并发静脉血栓栓塞的分子机制与风险评估[J].中国分子心脏病学杂志,2021,21(6):4380-4383. doi:10.16563/j.cnki.1671-6272.2021.12.021http://dx.doi.org/10.16563/j.cnki.1671-6272.2021.12.021.
庞李贺,杨华瑞,周耀君,等.miR-122-5p对滑膜肉瘤细胞株SW982增殖及放疗敏感性的影响[J].巴楚医学,2021,4(2):50-56.doi:10.3969/j.issn.2096-6113.2021.02.015http://dx.doi.org/10.3969/j.issn.2096-6113.2021.02.015.
边倩,曹妮,刘航,等.益脾养肝方对大鼠肝癌癌前病变miR-221表达的影响[J].陕西中医,2020,41(11):1515-1519.doi:10.3969/j.issn.1000-7369.2020.11.001http://dx.doi.org/10.3969/j.issn.1000-7369.2020.11.001.
王娜,龚莉莉,叶春梅.miR-146b-5p靶向ZNRF2影响IL-17a诱导乳腺癌细胞增殖、迁移和侵袭[J].中国免疫学杂志,2021,37(14):1738-1743.doi:10.3969/j.issn.1000-484X.2021.14.014http://dx.doi.org/10.3969/j.issn.1000-484X.2021.14.014.
Yang Y,Li F,Luo X,et al.Identification of LCN1 as a potential biomarker for breast cancer by bioinformatic analysis[J].DNA Cell Biol,2019,38(10):1088-1099.doi: 10.1089/dna.2019.4843http://dx.doi.org/10.1089/dna.2019.4843.
Wang JY,Kwon JS,Hsu SM,et al.Sensitive tear screening of diabetic retinopathy with dual biomarkers enabled using a rapid electrokinetic patterning platform[J].Lab Chip,2020,20(2):356-362.doi: 10.1039/c9lc00975bhttp://dx.doi.org/10.1039/c9lc00975b.
Zhang X,Cui Y,He M,et al.Lipocalin-1 expression as a prognosticator marker of survival in breast cancer patients[J].Breast Care (Basel),2020,15(3):272-280. doi: 10.1159/000503168http://dx.doi.org/10.1159/000503168.
0
浏览量
4
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621